SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,025,000 | -89.8% | 41,900 | -76.6% | 0.72% | -95.7% |
| Q4 2017 | $29,516,000 | +148.8% | 179,200 | -5.9% | 16.65% | +170.4% |
| Q3 2017 | $11,862,000 | +148.3% | 190,400 | +217.3% | 6.16% | +171.0% |
| Q2 2017 | $4,778,000 | -34.6% | 60,000 | -41.6% | 2.27% | -44.4% |
| Q1 2017 | $7,306,000 | +327.0% | 102,800 | +81.0% | 4.09% | +367.6% |
| Q2 2016 | $1,711,000 | – | 56,800 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |